These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7969965)

  • 1. Selegiline in the treatment of narcolepsy.
    Hublin C; Partinen M; Heinonen EH; Puukka P; Salmi T
    Neurology; 1994 Nov; 44(11):2095-101. PubMed ID: 7969965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study.
    Mayer G; Ewert Meier K; Hephata K
    Clin Neuropharmacol; 1995 Aug; 18(4):306-19. PubMed ID: 8665543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.
    Szabo ST; Hopkins SC; Lew R; Loebel A; Roth T; Koblan KS
    Sleep Med; 2023 Jul; 107():202-211. PubMed ID: 37209427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
    Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
    Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
    Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM changes in narcolepsy with selegiline.
    Reinish LW; MacFarlane JG; Sandor P; Shapiro CM
    Sleep; 1995 Jun; 18(5):362-7. PubMed ID: 7676170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A; Minz M; Beillevaire T; Degos C; Cathala HP
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Narcolepsy].
    Billiard M; Cadilhac J
    Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selegiline in narcolepsy.
    Roselaar SE; Langdon N; Lock CB; Jenner P; Parkes JD
    Sleep; 1987 Oct; 10(5):491-5. PubMed ID: 3120270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial.
    Elwes RD; Crewes H; Chesterman LP; Summers B; Jenner P; Binnie CD; Parkes JD
    Lancet; 1989 Nov; 2(8671):1067-9. PubMed ID: 2572797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and sleep EEG monitoring characteristics and long-term follow-up study on narcolepsy].
    Wang R; Qin J; Liu XY; Feng BR
    Zhonghua Er Ke Za Zhi; 2003 Jan; 41(1):11-3. PubMed ID: 14761316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.
    Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo.
    Schrader H; Kayed K; Bendixen Markset AC; Treidene HE
    Acta Neurol Scand; 1986 Oct; 74(4):297-303. PubMed ID: 3544654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.